or Try an Advanced Search...

    Treatment Of Major Depressive Disorder Stocks List

    Symbol Grade Name % Change
    ELYM B Eliem Therapeutics, Inc -2.40
    VNDA B Vanda Pharmaceuticals Inc. -1.51
    PRAX B Praxis Precision Medicines, Inc. 4.71
    BWAY C Brainsway Ltd. 1.93
    VTGN D VistaGen Therapeutics, Inc. -2.28
    NERV F Minerva Neurosciences, Inc -0.40
    BDRX F Biodexa Pharmaceuticals plc -7.20
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Major Depressive Disorder Depressive Disorder Neuroscience Biopharmaceutical Schizophrenia Antidepressants Central Nervous System Disorders Clinical Development Depression Disease Disorders Epilepsy Insomnia Mental Health Nervous System Disorders Neurophysiology Perimenopausal Depression Addiction Alcohol Antisense RNA

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Major Depressive Disorder stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 0.85
    AFSM C Active Factor Small Cap ETF 0.45
    LABD B Direxion Daily S&P Biotech Bear 3X Shares 0.35
    IWC C iShares Microcap ETF 0.24
    SBIO D ALPS Medical Breakthroughs ETF 0.16
    View all Treatment Of Major Depressive Disorder ETFs...
    Compare ETFs
    Compare AFSM to LABD Compare IWC to SBIO Compare LABD to IWC

        Treatment Of Major Depressive Disorder Stocks Recent News

        Date Stock Title
        Apr 24 VNDA Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
        Apr 24 VNDA Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
        Apr 24 VTGN Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression
        Apr 22 VNDA Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
        Apr 22 VNDA US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
        Apr 22 VNDA UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
        Apr 22 VNDA US Supreme Court reportedly declines to hear Vanda patent case
        Apr 22 VNDA U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
        Apr 19 BDRX Biodexa Pharmaceuticals reports Preliminary FY results
        Apr 19 VNDA Vanda under pressure from hedge fund to discuss Future Pak takeover offer
        Apr 19 VNDA Butler Hall Capital urges Vanda to engage in sales discussions
        Apr 19 BDRX Preliminary Results for the Year Ended 31 December 2023
        Apr 18 VNDA Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up
        Apr 18 VNDA Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Major Depressive Disorder Depressive Disorder Neuroscience Biopharmaceutical Schizophrenia Antidepressants Central Nervous System Disorders Clinical Development Depression Disease Disorders Epilepsy Insomnia Mental Health Nervous System Disorders Neurophysiology Perimenopausal Depression Addiction Alcohol Antisense RNA
        Treatment Of Major Depressive Disorder

        Treatment of major depressive disorder typically involves a combination of psychotherapy and medication. Psychotherapy may include cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), and/or psychodynamic therapy. Medication may include antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). Other treatments may include electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS).

        Browse All Tags